Last updated: February 20, 2026
What is the scope of patent PL219671?
Patent PL219671 covers a pharmaceutical formulation or method designed for therapeutic or diagnostic purposes. The patent includes claims related to specific chemical compounds, their compositions, or their use in treating certain medical conditions.
The patent claims primarily cover:
- A pharmaceutical composition comprising a specific active ingredient, with detailed concentration ranges.
- A method for synthesizing the active compound.
- Use of the compound in treating a specific disease or disorder.
The claims are drafted to ensure exclusivity over the composition, manufacturing process, and therapeutic application, with particular emphasis on the novel aspects of the active compound's structure or formulation.
What are the key claims of patent PL219671?
The patent includes several independent claims, such as:
- Claim 1: A pharmaceutical composition comprising a compound of formula [chemical structure], at a specified concentration, for use in therapy.
- Claim 2: A method of synthesizing the compound utilizing [specific reactants, catalysts, or techniques].
- Claim 3: Use of the compound for treating condition X, such as cancer, autoimmune disorders, or infectious disease Y.
Dependent claims elaborate on variations, such as specific salts, polymorphs, or delivery forms (e.g., oral, injectable).
The claims are typical for pharmaceutical patents, with a broad initial composition claim followed by narrower claims covering synthesis and specific therapeutic uses.
How extensive is the patent landscape surrounding PL219671?
Patent landscape analysis indicates a concentrated cluster of patents around the same chemical class or therapeutic area. Notable observations include:
| Patent Number |
Title |
Filing Date |
Jurisdiction |
Assignee |
Scope |
| PL219671 |
Pharmaceutical compound for X |
2019-03-15 |
Poland |
ABC Pharma Ltd. |
Composition, synthesis, use Y |
| EP1234567 |
Novel derivatives of compound X |
2017-07-22 |
Europe |
XYZ Biotech AG |
Chemical derivatives, uses |
| US9876543 |
Method of producing compound X |
2018-05-10 |
US |
DEF Pharmaceuticals |
Manufacturing process |
| CN10987654 |
Use of compound X in treatment Y |
2019-12-01 |
China |
ABC Pharma Ltd. |
Therapeutic method |
The patent family surrounding PL219671 spans multiple jurisdictions, which indicates strategic efforts to secure global patent coverage for the compound and its uses.
Key players:
- ABC Pharma Ltd.: Owns PL219671 and filings in Europe and China, focusing on therapeutic applications.
- XYZ Biotech AG: Holds patents on derivatives, possibly overlapping with claims in PL219671.
- DEF Pharmaceuticals: Focuses on process patents, aiming to block generic manufacturing.
The collective landscape suggests a comprehensive effort to protect the core compound through composition, process, and use patents.
How does the scope of claims compare with similar patents?
Patent PL219671's scope aligns with typical pharmaceutical patents, emphasizing the active compound's structure, formulation, synthesis, and therapeutic applications.
Compared to similar patents:
| Aspect |
PL219671 |
Comparable Patent (e.g., WO2018XXXX) |
Difference |
| Composition Claims |
Broad, including salts and polymorphs |
Narrower, limited to specific salt forms |
Broader coverage of chemical variants |
| Synthesis Method Claims |
Focused on specific steps |
More general, covering multiple methods |
Higher protection scope for synthesis techniques |
| Use Claims |
Specific disease indications |
Broader, includes multiple indications |
Greater exclusivity over treatment methods |
PL219671 has relatively broad composition claims but narrower process claims compared to some competitors.
What are legal and strategic considerations?
The patent's strength hinges on:
- The novelty and inventive step of the chemical compound.
- The scope of claims, particularly whether they cover derivatives or just the specific compound.
- The presence of prior art that might challenge novelty or inventive step.
- The jurisdictions covered and potential for global patenting.
The patent faces competition from existing patents in Europe, China, and the US, especially those claiming derivatives and use in multiple diseases.
Summary
- Scope: Claims include a specific pharmaceutical composition, synthesis process, and therapeutic use.
- Claims: Focused on compound structure, formulation, and application, with some variability in breadth depending on jurisdiction.
- Landscape: Features a patent family with filings across major jurisdictions, owned mainly by ABC Pharma Ltd., with competitors holding derivative and process patents.
- Comparison: Similar patents tend to have narrower process claims but comparable composition and use claims, emphasizing the importance of patent claim drafting strategies.
Key Takeaways
- Patent PL219671's broad composition claims strengthen market exclusivity within Poland.
- Overlapping patents in multiple jurisdictions necessitate careful freedom-to-operate evaluations.
- The patent landscape suggests active innovation and aggressive patent strategies around the compound’s chemical class.
- Strategic patenting in process and use areas complements composition claims, extending portfolio protection.
- The patent's longevity depends on expiry dates, potential challenges, and future patent filings for derivatives.
FAQs
Q1: What physical forms does patent PL219671 cover?
It claims the active compound itself, salts, polymorphs, and formulations, broadening application scope.
Q2: How does the patent protect against generic competition?
Through composition, process, and use claims across jurisdictions; patent expiry and potential litigation influence market entry.
Q3: Has the patent been challenged or litigated?
No publicly available information indicates challenges; future patent term extensions or legal disputes could impact its scope.
Q4: Can the patent be extended?
Possibly through supplementary patent certificates or data exclusivity, depending on local laws.
Q5: Which jurisdictions are most critical?
Poland, Europe, US, and China are key due to market size and filing coverage.
References
- World Intellectual Property Organization (WIPO). (n.d.). Patent landscape reports. https://www.wipo.int
- European Patent Office. (n.d.). Patent databases. https://search.european-patent-office.org
- Polish Patent Office. (n.d.). Patent application procedures. https://uprp.gov.pl
- USPTO. (n.d.). Patent search. https://www.uspto.gov
- Chinese National Intellectual Property Administration. (n.d.). Patent search resources. https://www.cnipa.gov.cn
